CHP
TCON

Cable Hill Partners’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Cable Hill Partners’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10
Closed -$7K – 967
2017
Q4 		$7K Buy
10
+5
+100% +$3.02K ﹤0.01% 677
2017
Q3 		$3K Buy
+5
New +$2.6K ﹤0.01% 898

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Cable Hill Partners's TCON Position: Q1 2018 in Review

Cable Hill Partners sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q1 2018, closing a stake of 10 shares — an estimated $7K sold.

Cable Hill Partners first reported a position in TCON in Q3 2017 and held it in 2 quarters. The position peaked at $7K in Q4 2017. 33 funds tracked by Wall St. Rank hold TCON as of Q1 2018.

  • Cable Hill Partners reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Cable Hill Partners sold 10 TRACON Pharmaceuticals, Inc. Common Stock shares in Q1 2018, an estimated $7K.
  • Cable Hill Partners first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Cable Hill Partners's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $7K in Q4 2017.
  • 33 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q1 2018.

Based on Cable Hill Partners's 13F filing for Q1 2018, filed 20 Apr 2018.